Publicaciones (36) Publicaciones de DULCE MARIA CAMPOS BLANCO

2023

  1. Proposed Recommendations for the Management of Depression in Adults with Epilepsy: An Expert Consensus

    Neurology and Therapy, Vol. 12, Núm. 2, pp. 479-503

  2. Real-life evidence about the use of intravenous brivaracetam in urgent seizures: The BRIV-IV study

    Epilepsy and Behavior, Vol. 147

2021

  1. COVID-19 prevalence and mortality in people with epilepsy: A nation-wide multicenter study

    Epilepsy and Behavior, Vol. 125

2020

  1. Effectiveness and safety of perampanel monotherapy for focal and generalized tonic-clonic seizures: Experience from a national multicenter registry

    Epilepsia, Vol. 61, Núm. 6, pp. 1109-1119

  2. Observational multicentre study into the use of antiepileptic drugs in Spanish neurology consultations

    Neurologia, Vol. 35, Núm. 2, pp. 115-125

2019

  1. BRIVA-LIFE–A multicenter retrospective study of the long-term use of brivaracetam in clinical practice

    Acta Neurologica Scandinavica, Vol. 139, Núm. 4, pp. 360-368

  2. Clinical outcomes of eslicarbazepine acetate monotherapy for focal-onset seizures: A multicenter audit

    Acta Neurologica Scandinavica, Vol. 140, Núm. 6, pp. 422-428

  3. Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study

    Neurology and Therapy, Vol. 8, Núm. 2, pp. 491-504

2018

  1. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis

    The Lancet Neurology, Vol. 17, Núm. 9, pp. 760-772

  2. Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study

    Epilepsia, Vol. 59, Núm. 9, pp. 1740-1752

2017

  1. EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure

    Acta Neurologica Scandinavica, Vol. 136, Núm. 3, pp. 254-264

  2. Efficacy and safety of eslicarbazepine acetate monotherapy for partial-onset seizures: Experience from a multicenter, observational study

    Epilepsy and Behavior, Vol. 73, pp. 173-179

  3. Erratum to “Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study” [Epilepsy Res. (2016) 126 (201–210)] (S0920121116301218)(10.1016/j.eplepsyres.2016.08.001)

    Epilepsy Research

2016

  1. Actualización en el manejo de la crisis comicial en urgencias: protocolo de actuación del Servicio de Urgencias del HCU Valladolid (versión 1.0.1)

    Ergon

  2. Palinacusia secundaria a daño cerebral por metotrexato

    Acta Otorrinolaringologica Espanola, Vol. 67, Núm. 6, pp. 349-351

  3. Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA study

    Epilepsy Research, Vol. 126, pp. 201-210

2015

  1. Early Add-on Lacosamide in a Real-Life Setting: Results of the REALLY Study

    Clinical Drug Investigation, Vol. 35, Núm. 2, pp. 121-131

2013

  1. Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide

    Epilepsy and Behavior, Vol. 29, Núm. 2, pp. 349-356

2012

  1. Hemicrania continua in a headache clinic: Referral source and diagnostic delay in a series of 22 patients

    Journal of Headache and Pain, Vol. 13, Núm. 7, pp. 567-569

  2. Hemicrania continua: Characteristics and therapeutic experience in a series of 36 patients

    Revista de Neurologia, Vol. 55, Núm. 5, pp. 270-278